- Home
- AGNC vs ELAN Comparison
AGNC vs ELAN Comparison
Compare AGNC & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGNC | ELAN |
|---|---|---|
| Founded | 2008 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 12.2B |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AGNC | ELAN |
|---|---|---|
| Price | $10.19 | $23.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | $11.03 | ★ $27.89 |
| AVG Volume (30 Days) | ★ 15.8M | 4.3M |
| Earning Date | 04-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 13.13% | N/A |
| EPS Growth | ★ 58.06 | N/A |
| EPS | ★ 0.37 | 0.22 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $0.33 | $8.21 |
| Revenue Next Year | $1.16 | $5.31 |
| P/E Ratio | ★ $28.49 | $107.05 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $9.63 | $18.22 |
| 52 Week High | $12.19 | $27.98 |
Technical Indicators
Market Signals| Indicator | AGNC | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 31.45 | 40.86 |
| Support Level | $10.28 | $21.89 |
| Resistance Level | $10.64 | $25.24 |
| Average True Range (ATR) | 0.17 | 0.68 |
| MACD | -0.05 | -0.07 |
| Stochastic Oscillator | 6.25 | 2.25 |
Price Performance
Historical ComparisonAbout AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.